U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
LIRENTELIMAB
INN   USAN  
Official Name English
AK-002
Preferred Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN SIALIC ACID-BINDINGE IG-LIKE LECTIN 8) (HUMAN-MUS MUSCULUS MONOCLONAL AK002 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL AK002 .KAPPA.-CHAIN, DIMER
Common Name English
ANTOLIMAB
Common Name English
LIRENTELIMAB [USAN]
Common Name English
MONOCLONAL ANTIBODY AK002
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS SIALIC ACID-BINDING IG-LIKE LECTIN 8 (SIALOADHESIN FAMILY MEMBER 2, SIGLEC-8, SAF-2))HUMANIZED MOUSE MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-450) (VH (HOMO SAPIENS IGHV3-66*01 (79%) (IGHD)-IGHJ5*01 (91%)/MUS
Common Name English
Lirentelimab [WHO-DD]
Common Name English
AK002
Code English
lirentelimab [INN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 628417
Created by admin on Tue Apr 01 21:04:21 GMT 2025 , Edited by admin on Tue Apr 01 21:04:21 GMT 2025
NCI_THESAURUS C129822
Created by admin on Tue Apr 01 21:04:21 GMT 2025 , Edited by admin on Tue Apr 01 21:04:21 GMT 2025
FDA ORPHAN DRUG 623017
Created by admin on Tue Apr 01 21:04:21 GMT 2025 , Edited by admin on Tue Apr 01 21:04:21 GMT 2025
FDA ORPHAN DRUG 668818
Created by admin on Tue Apr 01 21:04:21 GMT 2025 , Edited by admin on Tue Apr 01 21:04:21 GMT 2025
FDA ORPHAN DRUG 693519
Created by admin on Tue Apr 01 21:04:21 GMT 2025 , Edited by admin on Tue Apr 01 21:04:21 GMT 2025
NCI_THESAURUS C20401
Created by admin on Tue Apr 01 21:04:21 GMT 2025 , Edited by admin on Tue Apr 01 21:04:21 GMT 2025
Code System Code Type Description
NCI_THESAURUS
C129591
Created by admin on Tue Apr 01 21:04:21 GMT 2025 , Edited by admin on Tue Apr 01 21:04:21 GMT 2025
PRIMARY
INN
11511
Created by admin on Tue Apr 01 21:04:21 GMT 2025 , Edited by admin on Tue Apr 01 21:04:21 GMT 2025
PRIMARY
CAS
2283348-97-8
Created by admin on Tue Apr 01 21:04:21 GMT 2025 , Edited by admin on Tue Apr 01 21:04:21 GMT 2025
PRIMARY
USAN
GH-173
Created by admin on Tue Apr 01 21:04:21 GMT 2025 , Edited by admin on Tue Apr 01 21:04:21 GMT 2025
PRIMARY
SMS_ID
300000008861
Created by admin on Tue Apr 01 21:04:21 GMT 2025 , Edited by admin on Tue Apr 01 21:04:21 GMT 2025
PRIMARY
WIKIPEDIA
Lirentelimab
Created by admin on Tue Apr 01 21:04:21 GMT 2025 , Edited by admin on Tue Apr 01 21:04:21 GMT 2025
PRIMARY
FDA UNII
SWS48LJU3T
Created by admin on Tue Apr 01 21:04:21 GMT 2025 , Edited by admin on Tue Apr 01 21:04:21 GMT 2025
PRIMARY
ACTIVE MOIETY
LIRENTELIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966